Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,288,061
+$1,873,586 QoQ
Shares Held
6,910
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#1,363
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RESOURCES MANAGEMENT CORP /CT/ /ADV holds $58,736,749 across 9 Drug Manufacturers - General names. LLY ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
85,694 | $21,564,038 | |
| 2 | JNJ |
Johnson & Johnson
|
57,899 | $14,704,609 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
6,910 | $8,288,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
58,507 | $7,518,149 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
20,373 | $2,573,924 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,375 | $1,577,347 | |
| 7 | AMGN |
Amgen Inc
|
3,432 | $1,242,795 | |
| 8 | PFE |
Pfizer Inc
|
39,710 | $956,216 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,288,061 | 6,910 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,414,475 | 6,974 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,571,121 | 7,045 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,307,428 | 6,956 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,841,523 | 4,928 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,865,081 | 3,469 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,597,780 | 3,365 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,514,957 | 1,710 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,328,192 | 1,467 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,147,491 | 1,475 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $810,841 | 1,391 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $717,605 | 1,336 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $544,485 | 1,161 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $13 | 232 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $131,702 | 360 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $116,406 | 360 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $116,722 | 360 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $100,229 | 350 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $110,488 | 400 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $92,420 | 400 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $91,808 | 400 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $74,728 | 400 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $75,978 | 450 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $66,609 | 450 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $188,807 | 1,150 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $159,528 | 1,150 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||